- Home/In The News/Blog
14
August2013
category:
503b CompoundingHarkin Urges Passage of Compounding Bill
The FDA’s latest action, involving bacterial infections potentially associated with a compounding pharmacy’s product, shows the Pharmaceutical Quality, Security, and Accountability Act should be enacted, the HELP chairman said. After the FDA announced a nationwide recall of all sterile use products produced and distributed by Specialty Compounding, LLC of Cedar Park, Texas, the office […]
read more13
August2013
category:
503b CompoundingTImes of India – NPPA decision leads to acute drug shortage
MYSORE: City is facing acute shortage of several essential drugs and situation may worsen in the days to come. This is said to be the fall out of union government’s constitution of National Pharmaceuticals Pricing Authority(NPPA) which has the sole powers to fix the price of a particular drug by taking it’s production costs and […]
read more13
August2013
category:
503b CompoundingJPML Creates Federal MDL For Franck’s Compounding Pharmacy Actions
WASHINGTON, D.C. – The Judicial Panel on Multidistrict Litigation on Aug. 7 created a consolidated docket for all federal lawsuits brought against Franck’s Lab Inc. and Franck’s Pharmacy Inc. involving their compounded pharmaceutical products. The 20 actions regard injuries allegedly caused by drugs compounded by Franck’s that were contaminated by fungus or other toxins and […]
read more